Canada Markets closed

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.3350-0.0070 (-2.05%)
At close: 04:00PM EST
0.3310 -0.00 (-1.19%)
After hours: 04:28PM EST

Agile Therapeutics, Inc.

101 Poor Farm Road
Princeton, NJ 08540
United States
609 683 1880

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees28

Key Executives

NameTitlePayExercisedYear Born
Mr. Alfred F. AltomariChairman & CEO894.05kN/A1959
Mr. Dennis P. ReillySr. VP & CFO550.76kN/A1959
Mr. Geoffrey P. GilmoreSr. VP, Gen. Counsel & Corp. Sec.701.53kN/A1966
Jason ButchVP & Chief Accounting OfficerN/AN/AN/A
Ms. Tristen HerrstromSr. VP of HR & Admin.N/AN/AN/A
Matthew RileyHead of Investor Relations & Corp. CommunicationsN/AN/AN/A
Ms. Amy WelshVP of MarketingN/AN/AN/A
Mr. Robert G. ConwaySr. VP & Chief Supply Chain OfficerN/AN/A1957
Dr. Elizabeth Ijeoma Onyemelukwe Garner M.D., M.P.H.ConsultantN/AN/A1968
Dr. Paul KornerSr. VP & Chief Medical OfficerN/AN/A1966
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.

Corporate Governance

Agile Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.